T0	Outcomes 799 868	absolute change from baseline in glycated haemoglobin A(1c) (HbA(1c))
T1	Outcomes 914 956	achieving a therapeutic glycaemic response
T2	Outcomes 980 1049	baseline in fasting plasma glucose (Week 24); safety and tolerability
T3	Outcomes 1267 1272	139).
T4	Outcomes 1273 1300	Baseline mean (SD) HbA(1c):
T5	Outcomes 1336 1344	MET-UP).
T6	Outcomes 1345 1394	Adjusted mean reductions from baseline in HbA(1c)
T7	Outcomes 1557 1599	achieving a therapeutic glycaemic response
T8	Outcomes 1731 1770	were observed for diarrhoea-predominant
T9	Outcomes 1804 1820	[4.6, 11.2]) and
T10	Outcomes 1932 1945	adverse event